Working… Menu

DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer (DIRECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02126449
Recruitment Status : Completed
First Posted : April 30, 2014
Last Update Posted : October 24, 2019
Borstkanker Onderzoek Groep
Pink Ribbon Inc.
Information provided by (Responsible Party):
J.R. Kroep, Leiden University Medical Center